Non-Small Cell Lung Cancer、EGFR Sensitive Mutation
1 clinical trials · Condition
◉ Watch Non-Small Cell Lung Cancer、EGFR Sensitive Mutation
| Record | Firm | Date |
|---|---|---|
| Study of MCLA-129 Combined With Befotertinib in the Treatment of Advanced Non-small Cell Lung Cancer With EGFR Sensitive Mutation (NCT06015568) | Betta Pharmaceuticals Co., Ltd. | 2023-09-01 |
Track Non-Small Cell Lung Cancer、EGFR Sensitive Mutation automatically
Every clearance here is in the API, with alerts when new ones post.